These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 33316265)

  • 21. Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.
    Decourcelle A; Loison I; Baldini S; Leprince D; Dehennaut V
    Biochem Biophys Res Commun; 2020 Jan; 521(1):125-130. PubMed ID: 31630803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation.
    Gorelik A; Bartual SG; Borodkin VS; Varghese J; Ferenbach AT; van Aalten DMF
    Nat Struct Mol Biol; 2019 Nov; 26(11):1071-1077. PubMed ID: 31695185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
    Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
    Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular Interrogation to Crack the Case of O-GlcNAc.
    Estevez A; Zhu D; Blankenship C; Jiang J
    Chemistry; 2020 Sep; 26(53):12086-12100. PubMed ID: 32207184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. O-GlcNAcylation and neurodegeneration.
    Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
    Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical and Biochemical Strategies To Explore the Substrate Recognition of O-GlcNAc-Cycling Enzymes.
    Hu CW; Worth M; Li H; Jiang J
    Chembiochem; 2019 Feb; 20(3):312-318. PubMed ID: 30199580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1.
    Lima VV; Giachini FR; Carneiro FS; Carneiro ZN; Saleh MA; Pollock DM; Fortes ZB; Carvalho MH; Ergul A; Webb RC; Tostes RC
    Hypertension; 2010 Jan; 55(1):180-8. PubMed ID: 19948983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulating the Regulators: Mechanisms of Substrate Selection of the O-GlcNAc Cycling Enzymes OGT and OGA.
    Stephen HM; Adams TM; Wells L
    Glycobiology; 2021 Aug; 31(7):724-733. PubMed ID: 33498085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
    Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
    J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ac
    Wang H; Guo J; Wang N; Wang J; Xue Q; Wang J; Liu W; Liu K; Cao X; Zhao W; Xi R; Niu Y; Wang P; Li J
    Bioorg Med Chem Lett; 2019 Mar; 29(6):802-805. PubMed ID: 30713024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drosophila O-GlcNAcase Deletion Globally Perturbs Chromatin O-GlcNAcylation.
    Akan I; Love DC; Harwood KR; Bond MR; Hanover JA
    J Biol Chem; 2016 May; 291(19):9906-19. PubMed ID: 26957542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
    Sermikli BP; Aydogdu G; Yilmaz E
    Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of O-GlcNAcylation Homeostasis Induced Ovarian Granulosa Cell Injury in Bovine.
    Wang TF; Feng ZQ; Sun YW; Zhao SJ; Zou HY; Hao HS; Du WH; Zhao XM; Zhu HB; Pang YW
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.
    Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of transcription factor function by O-GlcNAc modification.
    Ozcan S; Andrali SS; Cantrell JE
    Biochim Biophys Acta; 2010; 1799(5-6):353-64. PubMed ID: 20202486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein
    Dos Passos Junior RR; de Freitas RA; Dela Justina V; San Martín S; Lima VV; Giachini FR
    Front Endocrinol (Lausanne); 2022; 13():1032499. PubMed ID: 36531508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycosylation with O-linked β-N-acetylglucosamine induces vascular dysfunction via production of superoxide anion/reactive oxygen species.
    Souza-Silva L; Alves-Lopes R; Silva Miguez J; Dela Justina V; Neves KB; Mestriner FL; Tostes RC; Giachini FR; Lima VV
    Can J Physiol Pharmacol; 2018 Mar; 96(3):232-240. PubMed ID: 28793197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. O-GlcNAc cycling enzymes control vascular development of the placenta by modulating the levels of HIF-1α.
    Yang YR; Jang HJ; Lee YH; Kim IS; Lee H; Ryu SH; Suh PG
    Placenta; 2015 Oct; 36(10):1063-8. PubMed ID: 26286378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.
    Dassanayaka S; Brittian KR; Jurkovic A; Higgins LA; Audam TN; Long BW; Harrison LT; Militello G; Riggs DW; Chitre MG; Uchida S; Muthusamy S; Gumpert AM; Jones SP
    Basic Res Cardiol; 2019 May; 114(4):28. PubMed ID: 31152247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.